Office of Research
Pediatric Early Phase Clinical Trials Network (UM1)
The purpose of this Funding Opportunity Announcement (FOA) is to enhance NCI’s program for conducting early phase clinical trials in children with cancer, currently supported as the Children's Oncology Group (COG) Phase 1 & Pilot Consortium. The overall goal is to ensure that high priority novel agents can be tested in pediatric patients in a timely manner. Towards this end, applications are solicited for the Pediatric Early Phase Clinical Trials Network (PEP-CTN) to continue the clinical research activities now supported through the COG Phase 1 & Pilot Consortium.
Application Instructions
Please submit:
- a 1-to-2 page letter of intent with a description of proposed aims and approach
- Biosketch or CV of the PI
- a letter of support from the Dean or Chair. This letter of support signifies that the Dean or Chair have ensured that the nominee and application are likely to be of sufficient quality to be competitive nationally
to research@uw.edu by 5:00 PM Thursday, July 20, 2017 Proposals are due to the sponsor 8/16/17, so you will need to have your materials in to the Office of Sponsored Programs by 8/8/17 for processing, if given the go ahead by the Proposal Review Committee.
Inquiries and Contact Information
Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.
For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.